Aandeel Hikma Pharmaceuticals | Filter Basic-Info
Aandeel: Hikma Pharmaceuticals
| Koers | 2062.00 | Hoogste koers | 2338.00 |
| Laagste koers | 1794.00 | 1-jrs rend. | 0.00 |
| Sector | Gezondheid | Subsector | Farmaceuten |
Contactinformatie:Staat: 13 Hanover SquarePostcode: W1S 1HWStad: LondonLand: EngelandWebsite: http://www.hikma.com/
Sectorvergelijking Hikma Pharmaceuticals
| Jaar | Omzet | Totaal omzet sector | Marktaandeel |
|---|---|---|---|
| 2019 | 16 | 474,682 | 0.00 % |
| 2020 | 17 | 469,262 | 0.00 % |
| 2021 | 18 | 566,698 | 0.00 % |
| 2022 | 20 | 640,029 | 0.00 % |
| 2023 | 22 | 590,473 | 0.00 % |
Adviezen Hikma Pharmaceuticals
No Records Found
Nieuws Hikma Pharmaceuticals
No Records Found
Rapporten Hikma Pharmaceuticals
No Records Found
Profiel Hikma Pharmaceuticals
Hikma Pharmaceuticals
/ HIKl
Hikma Pharmaceuticals is vooral actief in de farmaciesector. De internationale farmaciesector won ruim 75 procent over de periode 2006-2016. Sinds 2011 staat de sector 147 procent hoger en over de voorbije 12 maanden (december 2015-december 2016) 75 procent verlies.
2016: relatief goed beleggingsjaar voor het aandeel Hikma Pharmaceuticals
Over het voorbije jaar verloor het aandeel circa 19 procent. Hikma Pharmaceuticals's beurskoers nam de afgelopen 5 jaar ruim 0 procent in waarde af.
De farmaceut keerde in de voorbije 5 jaar geen dividenden uit.
Het Engelse bedrijf had eind 2015 circa 0 miljoen aandelen uitstaan.
Op this page vindt u alle jaarverslagen van Hikma Pharmaceuticals. Meer omtrent Hikma Pharmaceuticals kunt u vinden op 's website. .
Resultaten Hikma Pharmaceuticals
| Resultaten |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Omzet |
|
|
|
|
|
| Kosten |
|
|
|
|
|
| Nettowinst |
|
|
|
|
|
| Winstmarge |
|
|
|
|
|
| ROI |
|
|
|
|
|
Balans Hikma Pharmaceuticals
| Balans |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Eigen vermogen |
|
|
|
|
|
| Vreemd vermogen |
|
|
|
|
|
| Totaal vermogen |
|
|
|
|
|
| Solvabiliteit |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Kasstroom |
|
|
|
|
|
| Werknemers |
|
|
|
|
|
| Omzet per werknemer |
|
|
|
|
|
| Kasstroom / vreemd vermogen |
|
|
|
|
|
Details Hikma Pharmaceuticals
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Koers |
2301.00
|
1893.00
|
1134.00
|
1716.00
|
1991.00
|
| Winst per aandeel |
0.0
|
-2.00
|
0.0
|
1.00
|
1.00
|
| Koers / winst-verhouding |
0.0
|
-946.50
|
0.0
|
1716.00
|
2062.00
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Boekwaarde |
0.08
|
0.05
|
0.05
|
0.06
|
0.07
|
| Boek / koers |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Kasstroom per aandeel |
0.01
|
0.01
|
0.01
|
0.01
|
0.01
|
| Aandelen |
241
|
241
|
241
|
242
|
230
|
| Marktkap. |
554.541,00
|
455.605,14
|
273.809,97
|
415.819,40
|
475.204,40
|
Dividend Hikma Pharmaceuticals
Koersinfo Hikma Pharmaceuticals
|
Datum
|
Koers
|
|---|---|
|
25 jun
|
2062.00
|
|
20 jun
|
2056.00
|
|
07 jun
|
2128.00
|
|
03 jun
|
2148.00
|
|
28 mei
|
2112.00
|
|
27 mei
|
2076.00
|
|
19 mei
|
2070.00
|
|
09 mei
|
2024.00
|
|
01 mei
|
1985.00
|
|
29 apr
|
1937.00
|
|
22 apr
|
1885.00
|
|
09 apr
|
1794.00
|
|
08 apr
|
1794.00
|
|
03 apr
|
1937.00
|
|
30 maa
|
1963.00
|
|
27 maa
|
2010.00
|
|
26 maa
|
2006.00
|
|
20 maa
|
2022.00
|
|
15 maa
|
2012.00
|
|
12 maa
|
2104.00
|
|
01 maa
|
2160.00
|
|
25 feb
|
2304.00
|
|
23 feb
|
2310.00
|
|
18 feb
|
2318.00
|
|
13 feb
|
2338.00
|
|
12 feb
|
2338.00
|
|
07 feb
|
2284.00
|
|
05 feb
|
2272.00
|
|
02 feb
|
2292.00
|
|
21 jan
|
2084.00
|
